InflaRx IFRX
NASDAQ IFRX
$1.56 +0.03 (+1.96%)
At close: Oct 23, 2026 · 4:00 PM EDT

InflaRx (IFRX) Sale and Maturity of Investments (2018 - 2026)

Updated

Analysis

InflaRx (IFRX) Sale and Maturity of Investments (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 InflaRx 112.78 Mn -220.84 Mn 2.74 Mn 14.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.98 Mn
Mar 31, 2026 9.67 Mn
Dec 31, 2025 9.18 Mn
Sep 30, 2025 15.52 Mn
Jun 30, 2025 12.02 Mn
Mar 31, 2025 18.58 Mn
Dec 31, 2024 10.13 Mn
Sep 30, 2024 24.22 Mn
Jun 30, 2024 27.67 Mn
Mar 31, 2024 33.16 Mn
Dec 31, 2023 16.49 Mn
Sep 30, 2023 17.32 Mn
Jun 30, 2023 36.66 Mn
Mar 31, 2023 23.12 Mn
Dec 31, 2022 19.79 Mn
Sep 30, 2022 5.05 Mn
Jun 30, 2022 35.33 Mn
Mar 31, 2022 29.73 Mn
Dec 31, 2021 26.71 Mn
Sep 30, 2021 22.12 Mn
API Access

InflaRx Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=IFRX&period=max&api_key=YOUR_API_KEY